MDLZ vs THAR · P/E 30, rev $38.54B vs $187.4M cap
Mondelez International Inc (MDLZ) versus Tharimmune Inc. (THAR) — a side-by-side from cached financials, not a winner call.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Tharimmune Inc. (THAR) is a biotechnology company listed on NASDAQ.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
THAR does not have a complete income-statement cache yet.
MDLZ currently screens at market cap $78.12B and trailing P/E 30.1. THAR currently screens at market cap $187.4M.
Not investment advice. Open the MDLZ and THAR stock pages for the full models.
Not investment advice.